Latest news with #JamesChambers
The National
24-06-2025
- Politics
- The National
Palestine Action rejects 'sham investigation' over claims it is funded by Iran
Palestine Action has rejected 'baseless claims' it is being funded by Iran and called an investigation by the UK Home Office a 'sham'. The group, which broke into RAF Brize Norton airbase last week and damaged two planes, could be designated as a terrorist organisation if MPs approve a UK government plan next week. The Home Office is said to be investigating the group's funding and potential links to Iran, according to unnamed sources, The Times reported. But the group, which was co-founded by activist Huda Ammori and former XR campaigner Richard Barnard, said they had not been contacted. 'The Home Office did not inform us of their sham investigation, neither did they consult us on proscription,' a spokesperson for Palestine Action told The National on Tuesday. 'It is baseless and utterly ridiculous to suggest we are receiving funding from Iran.' The spokesperson accused the Home Office of spreading rumours to gain support for its move to ban the group. 'This is a deliberate attempt by the Home Office to smear Palestine Action, in a bid to bolster their draconian move to ban a protest group.' Palestine Actions donations, they said, came from 'ordinary people' who support the movement. Among them is James 'Fergie' Chambers, an American communist and heir to a multi-billion-pound conglomerate, who said in a 2023 interview that he was paying Palestine Action's legal fees. The Home Office refused to comment on Tuesday, after Cabinet minister Jonathan Reynolds said he could not rule out the possibility of a foreign power backing Palestine Action. 'It is extremely concerning they gained access to that base, and the Defence Secretary is doing an immediate review of how that happened,' he said in a BBC interview on Sunday. The campaign group engages in 'direct action' demonstrations that involve spray-painting the premises of Israeli arms manufacturer Elbit Systems and other companies they allege are linked to it. In recent months, Palestine Action prayed the London offices of Allianz Insurance with red paint because of its alleged links to Elbit, as well as US President Donald Trump's Turnberry golf course in South Ayrshire. It faces hundreds of thousands of pounds in legal fees as many of its activists face trial for charges such as criminal damage, burglary, blackmail and encouraging criminal damage. But the move to designate the group as a terrorist organisation – though popular in government – has raised concerns that it could be a step too far. The group has faced challenges opening bank accounts in recent months, before the proposal to designate them was floated. The Scottish Palestine Solidarity Campaign – which is not connected to the Palestine Solidarity Campaign based in London – said it had agreed to give Palestinian Action access to its banking services a 'few months ago'. But the proposed proscription has caused the Scottish Palestine Solidarity Campaign to think twice about the arrangement. 'We're reviewing that in a friendly way,' said Mick Napier, a spokesperson for the group. Hundreds of demonstrators in London supporting Palestine Action on Monday said they feared that the proposed designation was intended to diminish the wider mainstream support for Palestine. The Palestine Solidarity Campaign, which organises fortnightly marches in London and keeps a distance from Palestine Action, condemned the move as 'part of a wider crackdown on those protesting for Palestinian rights' that would 'only serve to degrade the meaning of terrorism'. If Parliament approves the order, Palestine Action will join the 81 organisations have been proscribed under the Terrorism Act 2000, including Islamist groups such as Hamas and Al Qaeda, far-right groups such as National Action, Russian private military company the Wagner Group and Hizb ut-Tahrir.
Yahoo
20-06-2025
- Business
- Yahoo
DuPont Extends its Costa Rica Healthcare Manufacturing Facility
DuPont de Nemours, Inc. (NYSE:DD) is among the 13 Best Hydrogen and Fuel Cell Stocks to Buy According to Analysts. It has added 16,000 square feet of operational space to its healthcare manufacturing facility in Heredia, Costa Rica. A closeup of a hand manipulating a complex piece of machinery in a semiconductor factory. This supports DuPont de Nemours, Inc. (NYSE:DD)'s global medical device supply chain and is the first sterile healthcare packaging operation in Costa Rica and the Caribbean. The facility now runs around the clock, creating sterile packaging made of Tyvek®, including lids, header bags, and pouches, and expanding its capacity for medical tubing. This development improves DuPont de Nemours, Inc. (NYSE:DD)'s sterile operations and extrusion capabilities throughout the Americas, solidifying the company's position in the healthcare industry. The expansion of the Heredia website reflects the rising need for superior sterile packaging and fluid management supplies. According to James Chambers, SVP and General Manager of Spectrum Plastics Group, a DuPont company, this action is evidence of DuPont de Nemours, Inc. (NYSE:DD)'s position as a reliable worldwide partner in the medical manufacturing industry. DuPont de Nemours, Inc. (NYSE:DD)'s portfolio now includes Spectrum Plastics, which was acquired in August 2023 and brings more than 60 years of experience in polymer processing and device production. Furthermore, the company produces PEM fuel cells, which are essential for electrolyzers that separate hydrogen and oxygen. While we acknowledge the potential of DD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy in 2025. Disclosure. None. Sign in to access your portfolio
Yahoo
06-06-2025
- Business
- Yahoo
DuPont expands Costa Rica facility for sterile packaging operations
US-based DuPont has expanded its healthcare manufacturing facility in Heredia, Costa Rica, adding sterile packaging capacity for the global medical device industry. This development also increases the capacity of the site's existing medical tubing operations. The Heredia site has grown by 16,000ft² to improve its operations, supporting healthcare customers in the Caribbean and across the Americas. Additional space houses new extrusion equipment and production lines, which will facilitate the production of sterile packaging utilising Tyvek products such as pouches, header bags, and lids. This expansion is expected to boost DuPont's extruded tubing production capacity. James Chambers, senior vice-president and general manager for fluids and flexibles at Spectrum Plastics Group, a DuPont Business, said: 'With this expansion, we are now the first company in Costa Rica and the Caribbean to produce fluid management and sterile packaging offerings for the medical device industry. 'This significantly enhances our robust, growing portfolio of unmatched offerings and capabilities as a trusted supply chain partner to leading global healthcare companies.' The facility's expansion has achieved International Organization for Standardization (ISO) 13485:2016 and ISO 9001:2015 certifications, ensuring that the technical, assembly, and packaging staff adhere to the highest quality standards and guidelines. The facility has transitioned to a 24/7 production schedule to meet the needs of both current and new customers. DuPont's offerings for the healthcare industry encompass extruded tubing and subassemblies, advanced catheter assembly, medical balloons, skin contact devices, smart wearables, additive manufacturing, laser processing, and more. In November 2024, DuPont launched Tyvek with Renewable Attribution, a new addition to its portfolio of Tyvek products designed for healthcare packaging. The company delivers full-service solutions that support a wide range of healthcare applications by combining medical-grade performance materials, component and device solutions, and innovative technology. "DuPont expands Costa Rica facility for sterile packaging operations" was originally created and published by Packaging Gateway, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Yahoo
05-06-2025
- Business
- Yahoo
DuPont Expands Healthcare Manufacturing Site in Costa Rica, Adding Sterile Packaging Capacity
The 16,000-square-foot expansion enhances DuPont's global sterile operations, increases the capacity of the manufacturing site's existing medical tubing operations, and enables Costa Rica's first-ever production of sterile healthcare packaging. WILMINGTON, Del., June 5, 2025 /PRNewswire/ -- DuPont (NYSE: DD) today announced that it has expanded its sterile operations via an addition to its healthcare manufacturing facility in Heredia, Costa Rica, enabling the site to produce sterile packaging for the global medical device industry while also increasing the capacity of the site's existing medical tubing operations. To serve Healthcare customers in the Caribbean and more broadly across the Americas, the Heredia operation has expanded by 16,000 square feet. The new space accommodates additional extrusion equipment and production lines, enabling production of sterile packaging leveraging Tyvek® – such as pouches, header bags and lids – and increasing DuPont's extruded tubing production capacity. The new expansion is ISO 13485:2016 and ISO 9001:2015 certified, with its technical, assembly and packaging staff adhering to the highest quality standards and protocols. To support current and new customers, the facility is operating on a 24/7 production schedule. "With this expansion, we are now the first company in Costa Rica and the Caribbean to produce fluid management and sterile packaging offerings for the medical device industry," said James Chambers, Senior Vice President and General Manager for Fluids & Flexibles at Spectrum Plastics Group, A DuPont Business. "This significantly enhances our robust, growing portfolio of unmatched offerings and capabilities as a trusted supply chain partner to leading global healthcare companies." DuPont's products, services and expertise for the healthcare industry include extruded tubing and subassemblies, advanced catheter assembly, medical balloons, skin contact devices, smart wearables, additive manufacturing, laser processing, precision injection-molding, medical device fabrication, machining and sterile packaging enabled by Tyvek®. Combining medical-grade performance materials, component and device solutions, and innovative technology, DuPont offers full-service, comprehensive solutions that support a range of healthcare applications. Learn more about DuPont's healthcare solutions at About Spectrum Plastics Group, A DuPont Business Acquired by DuPont in August 2023, Spectrum Plastics Group, A DuPont Business, brings over 60 years of expertise in advanced polymer processing and medical device manufacturing. The company specializes in precision extrusion, specialty injection molding, blown film extrusion and conversion, medical balloon fabrication, laser processing, additive manufacturing, and complex catheter and device assembly. Spectrum is recognized as a leading trusted supplier for the development and production manufacturing of critical polymer-based components and finished devices for the medical device market and other high-performance applications. With global facilities and more than 1 million square feet of manufacturing space, Spectrum delivers proven quality, innovation and technical excellence to solve the most demanding customer challenges. The company supports a broad range of healthcare applications across the biopharmaceutical processing, medical device and pharmaceutical markets. More information can be found at About DuPont DuPont (NYSE: DD) is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, healthcare and worker safety. More information about the company, its businesses and solutions can be found at Investors can access information included on the Investor Relations section of the website at DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted. View original content to download multimedia: SOURCE DuPont
